ArticleExpert review of clinical immunology2013

A possible turning point in the hematopoietic stem cell gene therapy for primary immunodeficiency diseases? Lentiviral vectors could take the place of retroviral vectors.

Tadashi ArigaPubMed ↗Publisher ↗

No numbers read from the abstract.